Corona Remedies Ltd (CORONA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039887, "name": "Corona Remedies", "stock_name": "Corona Remedies", "full_name": "Corona Remedies Ltd", "name_url": "stocks-analysis/corona-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,060.95", "chg": 14.95, "chgp": "0.73%", "dir": 1, "prev_price": "2,046.00", "mcapval": "12,598.00 Cr", "mcap": "Small Cap", "scripcode": 544644, "symbol": "CORONA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE02ZQ01018", "curr_date": "Aug 07, 03:30 PM", "curr_time": "18:22 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "26.19 k", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Corona Remedies Ltd Falls 1.75%: 6 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-falls-175-6-key-factors-driving-the-weeks-volatility-4142606", "imagepath": "", "date": "2026-08-08 09:02:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> New 52-week and all-time high at Rs.2,208.05</p>\n <p><strong>4 Aug:</strong> Further 52-week high at Rs.2,261.40 and all-time high close at Rs.2,225</p>\n <p><strong>5 Aug:</strong> Technical momentum shifts to bullish with strong intraday gains</p>\n <p><strong>6 Aug:</strong> Price correction and volume decline amid mixed technical signals</p>\n <p><strong>7 Aug:</strong> Mild recovery to close at Rs.2,060.95, still below weekly open</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class..." }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-signal-bullish-outlook-4137232", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_technicaldot_4137232.png", "date": "2026-08-05 08:08:13", "description": "Corona Remedies Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by positive signals from key technical indicators including MACD, Bollinger Bands, and Dow Theory, suggesting a strengthening price momentum that investors should closely monitor." }, { "title": "Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2261.4", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-new-52-week-high-at-rs-22614-4135620", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_priceRelatedfactors_4135620.png", "date": "2026-08-04 11:37:37", "description": "Surging to an all-time high of Rs 2261.4 on 4 Aug 2026, Corona Remedies Ltd has demonstrated remarkable price momentum, supported by a confluence of bullish technical indicators and sustained gains over recent sessions." }, { "title": "Corona Remedies Ltd Hits All-Time High of Rs 2,225 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-stock-hits-all-time-high-on-4-august-2026-4135605", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_priceRelatedfactors_4135605.png", "date": "2026-08-04 11:08:39", "description": "" }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4135649", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_technicaldot_4135649.png", "date": "2026-08-04 08:11:55", "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. This change is underscored by a combination of technical indicators including MACD, RSI, and moving averages, signalling a cautiously optimistic outlook for investors as the stock edges closer to its 52-week high." }, { "title": "Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2208.05", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-new-52-week-high-at-rs220805-4133289", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_priceRelatedfactors_4133289.png", "date": "2026-08-03 09:54:12", "description": "Surging to a fresh 52-week and all-time high of Rs 2208.05 on 3 Aug 2026, Corona Remedies Ltd demonstrated robust price momentum despite a modest underperformance relative to its sector. This milestone caps a year-long journey from a 52-week low of Rs 1336.95, underscoring the stock’s technical resilience amid a mixed market backdrop." }, { "title": "Strong Momentum Meets Stretched Valuations as Corona Remedies Ltd Reaches All-Time High", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-stock-hits-all-time-high-of-rs-220805-4133190", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemediesL_priceRelatedfactors_4133190.png", "date": "2026-08-03 09:38:03", "description": "" }, { "title": "Corona Remedies Q1 FY27: Strong 30% Profit Growth Fuels Bullish Momentum", "link": "https://www.marketsmojo.com/news/result-analysis/corona-remedies-q1-fy27-strong-30-profit-growth-fuels-bullish-momentum-4131856", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CoronaRemedies_quaterlyResult_4131856.png", "date": "2026-08-01 13:20:21", "description": "Corona Remedies Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹12,951 crores, delivered an impressive first quarter performance for FY2027, with consolidated net profit surging 30.11% year-on-year to ₹60.11 crores. The strong results, announced recently, propelled the stock to ₹2,097.60 as of July 31, 2026, marking a gain of 0.38% on the day and continuing its remarkable year-to-date rally of 51.36%." }, { "title": "Corona Remedies Ltd Falls 0.78%: 6 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-falls-078-6-key-factors-driving-the-weeks-momentum-4130951", "imagepath": "", "date": "2026-08-01 09:01:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> New 52-week high at Rs.2,139.55</p>\n <p><strong>28 Jul:</strong> Technical momentum shifts amid market volatility</p>\n <p><strong>30 Jul:</strong> New 52-week and all-time high at Rs.2,147.60</p>\n <p><strong>31 Jul:</strong> Mojo Grade upgraded to Buy with bullish technical signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,114.10</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,097.60</div><div class..." } ], "total": 57, "sid": "10039887", "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "03-Aug-2026", "details": "Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Aug-2026", "details": "Newspaper Publication of Unaudited Financial Results for the first quarter and three months ended June 30 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "31-Jul-2026", "details": "Press Release on Financial Results for Q1FY27", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26", "dt": "2026-06-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: New 52-week and all-time high at Rs.2,208.05

4 Aug: Further 52-week high at Rs.2,261.40 and all-time high close at Rs.2,225

5 Aug: Technical momentum shifts to bullish with strong intraday gains

6 Aug: Price correction and volume decline amid mixed technical signals

7 Aug: Mild recovery to close at Rs.2,060.95, still below weekly open

Week Open

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-05 08:08:13

Corona Remedies Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by positive signals from key technical indicators including MACD, Bollinger Bands, and Dow Theory, suggesting a strengthening price momentum that investors should closely monitor.

Read full news article

Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2261.4

2026-08-04 11:37:37

Surging to an all-time high of Rs 2261.4 on 4 Aug 2026, Corona Remedies Ltd has demonstrated remarkable price momentum, supported by a confluence of bullish technical indicators and sustained gains over recent sessions.

Read full news article

Corona Remedies Ltd Hits All-Time High of Rs 2,225 as Momentum Builds Across Timeframes

2026-08-04 11:08:39

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-08-04 08:11:55

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. This change is underscored by a combination of technical indicators including MACD, RSI, and moving averages, signalling a cautiously optimistic outlook for investors as the stock edges closer to its 52-week high.

Read full news article

Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2208.05

2026-08-03 09:54:12

Surging to a fresh 52-week and all-time high of Rs 2208.05 on 3 Aug 2026, Corona Remedies Ltd demonstrated robust price momentum despite a modest underperformance relative to its sector. This milestone caps a year-long journey from a 52-week low of Rs 1336.95, underscoring the stock’s technical resilience amid a mixed market backdrop.

Read full news article

Strong Momentum Meets Stretched Valuations as Corona Remedies Ltd Reaches All-Time High

2026-08-03 09:38:03

Read full news article

Corona Remedies Q1 FY27: Strong 30% Profit Growth Fuels Bullish Momentum

2026-08-01 13:20:21

Corona Remedies Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹12,951 crores, delivered an impressive first quarter performance for FY2027, with consolidated net profit surging 30.11% year-on-year to ₹60.11 crores. The strong results, announced recently, propelled the stock to ₹2,097.60 as of July 31, 2026, marking a gain of 0.38% on the day and continuing its remarkable year-to-date rally of 51.36%.